JW Therapeutics
Sustainability Report and Carbon Intensity Rankings
Is JW Therapeutics doing their part?
Their DitchCarbon score is 32
JW Therapeutics has a DitchCarbon Score of 32 out of 100, indicating room for improvement in sustainability practices. This score reflects a higher carbon intensity compared to more sustainable companies. Efforts to reduce emissions and enhance sustainability measures would be beneficial for JW Therapeutics to increase their score.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
JW Therapeutics is a company in the health and social services industry, which has a carbon intensity ranking of low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Unknown
High
Very high
JW Therapeutics, located in China, operates in a region with a specific carbon intensity rating. The sustainability of the company’s operations is influenced by China’s overall carbon footprint, which affects the environmental impact of their business practices.
Unlock 30+ emissions data points on JW Therapeutics
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on JW Therapeutics
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
9.56%
...this company is doing 9.56% worse in emissions than the industry average.
Founded in 2016, JW Therapeutics is a pioneering immuno-cell therapy company based in China, focusing on the cancer market within the Greater China region. The company is a collaborative effort between Juno Therapeutics and WuXi AppTec, combining advanced CAR and TCR technologies with extensive R&D and manufacturing capabilities. JW Therapeutics is dedicated to developing and promoting innovative cancer cellular immune-therapies, aiming to become a leader in the cell therapy industry in China.
emission intelligence's platform recommendations for JW Therapeutics
JW Therapeutics should undertake a thorough assessment of all direct emissions sources to identify and quantify their Scope 1 footprint.
Bad news, JW Therapeutics hasn't committed to SBTi goals yet
JW Therapeutics has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company has not publicly defined or committed to concrete targets for reducing its greenhouse gas emissions in line with climate science.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.